{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:33:45Z","timestamp":1774557225786,"version":"3.50.1"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Postherpetic neuralgia (PHN) and postherpetic pruritus (PHP) are common complications of shingles that affect patients\u2019 quality of life. PHN and PHP can be managed using various medications and interventional procedures; however, complications persisting for at least six months may hamper recovery. Subcutaneous injections of botulinum toxin type A (BTX-A) can control persistent PHN and PHP. Case presentation: A 71-year-old man presented at our hospital with itching and pain. He had been diagnosed with shingles in the ophthalmic branch of the trigeminal nerve one year previously. As the pain and itching persisted despite medication, a supraorbital nerve block, Gasserian ganglion block, epidural nerve block, and radiofrequency thermocoagulation were performed. A subcutaneous injection of BTX-A was administered into the ophthalmic area of the trigeminal nerve three years after the initial presentation. A decrease of &gt;80% in pain and itching was reported after the injection; however, the left eyelid drooped and the eyeball shifted downward and outward immediately after the injection. No deterioration in vision or pupil dilation was observed, and almost complete resolution of these symptoms occurred spontaneously three months after the injection. Pain and itching continued to improve without further side-effects until six months after the injection. Conclusions: The subcutaneous injection of BTX-A may be an alternative treatment option for chronic and refractory neurological diseases such as PHN and PHP, which persist for four years and are resistant to conventional treatments. Nevertheless, care must be taken to minimize the risk of ptosis.<\/jats:p>","DOI":"10.3390\/medicina60081317","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:20:51Z","timestamp":1723627251000},"page":"1317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years\u2014A Case Report"],"prefix":"10.3390","volume":"60","author":[{"given":"Jihyun","family":"Song","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Korea University Medical Center, Guro Hospital, 148 Gurodong Road, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-9886","authenticated-orcid":false,"given":"Sang Sik","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Korea University Medical Center, Guro Hospital, 148 Gurodong Road, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Jun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Korea University Medical Center, Guro Hospital, 148 Gurodong Road, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-3832","authenticated-orcid":false,"given":"Chung Hun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Korea University Medical Center, Guro Hospital, 148 Gurodong Road, Guro-gu, Seoul 08308, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/15360288.2023.2174632","article-title":"Analgesic treatment approach for postherpetic neuralgia: A narrative review","volume":"37","author":"Mendoza","year":"2023","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1532-5415.2007.01231.x","article-title":"Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster","volume":"55","author":"Dworkin","year":"2007","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","article-title":"Herpes zoster and quality of life: A self-limited disease with severe impact","volume":"45","author":"Lydick","year":"1995","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e30208","DOI":"10.1097\/MD.0000000000030208","article-title":"The relative frequency of pruritus in postherpetic neuralgia patients presenting to the pain clinic and associative factors","volume":"101","author":"Park","year":"2022","journal-title":"Medicine"},{"key":"ref_5","first-page":"e5665","article-title":"Postherpetic pruritus: A potential complication of herpes zoster virus infection","volume":"11","author":"Hassan","year":"2019","journal-title":"Cureus"},{"key":"ref_6","first-page":"88","article-title":"Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia","volume":"11","author":"Wallace","year":"2011","journal-title":"Pain Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3344\/kjp.2015.28.3.177","article-title":"Herpes zoster and postherpetic neuralgia: Practical consideration for prevention and treatment","volume":"28","author":"Jeon","year":"2015","journal-title":"Korean J. Pain"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","article-title":"Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia","volume":"9","author":"Dworkin","year":"2008","journal-title":"J. Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AJP.0b013e31827a72d2","article-title":"Botulinum toxin A in postherpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial","volume":"29","author":"Apalla","year":"2013","journal-title":"Clin. J. Pain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13181","DOI":"10.1111\/dth.13181","article-title":"Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia","volume":"33","author":"Hu","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Moon, Y.E., Choi, J.H., Park, H.J., Park, J.H., and Kim, J.H. (2016). Ultrasound-guided nerve block with botulinum toxin type A for intractable neuropathic pain. Toxins, 8.","DOI":"10.3390\/toxins8010018"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Park, J., and Park, H.J. (2017). Botulinum toxin for the treatment of neuropathic pain. Toxins, 9.","DOI":"10.3390\/toxins9090260"},{"key":"ref_16","first-page":"12","article-title":"Evaluation of botulinum toxin type A injection in the treatment of localized chronic pruritus","volume":"13","author":"Gharib","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ri, S., Kivi, A., and Wissel, J. (2021). The safety and effect of local botulinumtoxin A injections for long-term management of chronic pain in post-herpetic neuralgia: Literature review and cases report treated with incobotulinumtoxin A. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080758"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/mds.23254","article-title":"Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX\u00ae) across multiple indications","volume":"25","author":"Naumann","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1097\/PRS.0000000000001771","article-title":"Neurotoxins: Current concepts in cosmetic use on the face and neck: Upper face (glabella, forehead, and crow\u2019s feet)","volume":"136","author":"Monheit","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/CCID.S138274","article-title":"Tailored botulinum toxin type A injections in aesthetic medicine: Consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone","volume":"10","author":"Anido","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2009.06.040","article-title":"Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants","volume":"61","author":"Brin","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jocd.13875","article-title":"To click or not to click\u2014The importance of understanding the layers of the forehead when injecting neuromodulators\u2014A clinical, prospective, interventional, split-face study","volume":"20","author":"Davidovic","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_24","first-page":"30","article-title":"New anatomical insights into preventing brow ptosis with botulinum toxin-A use","volume":"2","author":"Sandre","year":"2021","journal-title":"Can. Dermatol. Today"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4097\/kja.19145","article-title":"Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: A randomized controlled trial","volume":"72","author":"Ryu","year":"2019","journal-title":"Korean J. Anesthesiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1526-4637.2005.05029.x","article-title":"Treatment of ptosis as a complication of botulinum toxin injection","volume":"6","author":"Omoigui","year":"2005","journal-title":"Pain Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:36Z","timestamp":1760110596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["medicina60081317"],"URL":"https:\/\/doi.org\/10.3390\/medicina60081317","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}